
Xingmai Technology
杏脉科技
Xingmai Technology
Biotech/Healthcare
Xingmai's product portfolio primarily focuses on AI applications in radiology, ultrasound, and pathology. According to CTO Fang Qu, the company has launched products for hospital testing that cover lung conditions, orthopedics, respiratory viruses, and TCT-based cervical cancer screening.
Latest round: Strategic (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.